Skip to main content

Essilor Value Stock - Dividend - Research Selection


ISIN: FR0000121667, WKN: 863195

Market price date: 21.05.2021
Market price: 142,90 EUR

Essilor Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 20-03-2021
Cash flow
Net operating cash flow 2.953.000.000
Capital Expenditures -650.000.000
Free cash flow 2.303.000.064
Balance sheet
Total Equity
Liabilities & Shareholders equity 52.318.000.000
Income statement
Net income 85.000.000
Eps (diluted) 0,194
Diluted shares outstanding 437.019.000
Net sales/revenue 14.429.000.000

Fundamental ratios calculated on: 21-05-2021

Key figures 21-05-2021
Cash flow
P/C 21,15
P/FC 27,12
Balance sheet
Income statement
Div. Yield1,56%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization75.742.896.128,00 USD
IndicesCAC 40,EURO STOXX 50
Raw Data SourceIFRS in Millionen EUR
Stock Split2007-07-16,2.000000/1.000000

Description of the company

Essilor International Compagnie Generale D'Optique SA is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals. It operates through three segments: Lenses and Optical Instruments, Equipment, and Sunglasses & Readers. It is a North American provider of non-prescription reading glasses. It also sells non-prescription sunglasses. It has approximately 32 plants, over 490 prescription laboratories, edging facilities and local distribution centers, and over five research and development centers across the world. The Company designs, manufactures and customizes corrective lenses. The Company provides a range of lenses for correcting myopia, hyperopia, astigmatism and presbyopia. The Company's flagship brands include Varilux, Crizal, Transitions, Eyezen, Xperio, Foster Grant, Bolon and Costa.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,